Equities

Nanexa AB

Nanexa AB

Actions
  • Price (SEK)1.60
  • Today's Change0.00 / 0.00%
  • Shares traded59.85k
  • 1 Year change-37.01%
  • Beta1.4199
Data delayed at least 15 minutes, as of Sep 20 2024 09:46 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Nanexa AB is a Sweden-based company engaged in the drug delivery systems industry. The Company specializes in the nanotechnology and research and development in life science. Its products portfolio is comprised of PharmaShell, a drug delivery system that allows for targeting and dosing of drugs; antifungal coating, a system that protects medical products from the in-growth of fungi; and low-friction coating for peripheral venous catheters.

  • Revenue in SEK (TTM)26.91m
  • Net income in SEK-66.68m
  • Incorporated2010
  • Employees19.00
  • Location
    Nanexa ABVirdings Alle 32BUPPSALA 754 50SwedenSWE
  • Phone+46 18100300
  • Websitehttps://nanexa.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Glycorex Transplantation AB (publ)31.03m-27.83m119.29m15.00--3.26--3.84-0.3768-0.37680.42010.51860.4120.83823.691,348,913.00-36.96-11.30-46.32-13.1782.9191.60-89.70-33.241.09-71.860.2084---17.04-2.15-254.06---0.5593--
Iconovo AB6.10m-39.03m119.71m29.00--0.9747--19.63-3.01-3.010.45267.710.0434--1.04210,251.40-27.76-25.43-31.28-28.24323.68134.57-640.15-215.16----0.0669---58.65-9.884.71--34.70--
BibbInstruments AB0.00-11.84m128.49m4.00--3.72-----0.4417-0.44170.001.180.00-------31.46-39.57-33.52-42.71--59.36---8,032.404.34--0.00------2.72---1.94--
Phase Holographic Imaging PHI AB9.12m-21.81m146.16m17.00------16.02-0.8819-0.88190.3689-0.02730.23730.65981.18---56.73-62.04-88.25-79.6471.0663.16-239.04-328.500.1916-5.611.04--6.1617.9612.98--21.19--
Immunovia AB (publ)885.00k-116.12m171.91m10.00--4.39--194.25-1.30-1.300.00990.21620.0071--14.3980,454.55-93.50-41.33-133.56-44.24-6,702.03-7,553.76-13,120.79-20,879.29--2.480.3064--37.5536.48-84.09---50.93--
Vo2 Cap Holding AB (publ)344.05m-3.18m173.49m95.00--0.75653.910.5043-0.0594-0.05946.494.030.7088--7.973,340,253.00-0.6554-0.2564-0.8674-0.383935.8423.36-0.9246-0.2409--0.32010.1362---26.0985.65-57.92---17.96--
Neola Medical AB0.00-9.47m182.39m7.00--2.47-----0.1508-0.15080.001.050.00----0.00-12.63-17.04-13.59-18.46--4,237.20---5,258.78----0.00------12.97--55.46--
Arcoma AB175.30m12.66m200.42m31.0015.843.5510.031.140.95980.959813.304.282.023.969.195,654,936.0014.611.1224.242.0137.8537.667.220.75681.2518.830.04070.0030.366.4134.81--22.75--
Bactiquant A/S13.66m-22.02m214.37m----20.64--15.69-0.6558-0.65580.40640.29060.51012.945.06---82.23-41.26-92.65-47.16-24.3412.89-161.20-71.772.73-9.480.5326---0.689--7.62------
Nanexa AB26.91m-66.68m217.11m19.00--2.50--8.07-0.6938-0.69380.24840.64110.2108-3.832.991,416,316.00-52.24-40.77-70.59-48.77118.7777.27-247.79-532.261.92--0.0174--925.42147.00-30.44--39.10--
SpectraCure AB (publ)2.36m-21.18m220.97m13.00--1.88--93.47-0.218-0.2180.02431.210.0166--24.63157,600.00-14.82-12.75-15.91-13.62442.39195.30-895.85-494.40----0.0494---3.30--19.46------
Nexstim Oyj89.82m-9.45m279.32m39.00--13.19--3.11-0.1223-0.12231.190.27610.81960.22235.28214,040.30-8.62-26.77-14.02-43.9097.2492.11-10.52-38.381.24-5.510.7716---23.9422.08-201.58--19.51--
Scandinavian Medical Solutions A/S300.32m8.17m279.34m25.0034.022.3815.160.93010.19630.19637.222.811.381.8911.35--3.75--6.15--24.48--2.72--0.43075.540.3473--72.98--7.49------
INIFY Laboratories AB3.42m-51.45m303.14m23.00--4.14--88.56-1.17-1.170.07811.670.0322.990.6608---48.10---48.10--76.42---1,503.10------0.00--------------
Ortoma AB43.22m-30.78m308.15m7.00--1.86--7.13-0.8112-0.81121.244.670.22941.014.496,173,962.00-16.34-10.45-17.53-11.6486.83339.86-71.22-175.523.04--0.00-------38.87--14.14--
Micropos Medical AB (publ)2.68m-22.68m312.88m9.00--15.29--116.70-0.2463-0.24630.0220.13410.09940.13151.20335,122.50-84.10-64.24-111.33-82.2779.96114.76-845.91-767.573.18--0.0184--50.235.94-26.57------
Data as of Sep 20 2024. Currency figures normalised to Nanexa AB's reporting currency: Swedish Krona SEK

Institutional shareholders

0.02%Per cent of shares held by top holders
HolderShares% Held
FCG Fonder ABas of 30 Aug 202425.04k0.02%
Data from 30 Aug 2024 - 30 Aug 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.